Sabra Health Care REIT, Inc.
SBRA Nasdaq
SEC CIK 1492298
Follow Sabra Health Care REIT
Weekly email: filings, results
Revenue, last quarter
$143.2M
+55.6% vs same quarter last year
Net income
$28.6M
+26.9% vs same quarter last year
EPS, diluted
$0.11
+22.2% vs same quarter last year
Operating cash flow
$129M
+29% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $356.9M | $155.6M |
| FY24 | $284.6M | $126.7M |
| FY23 | $236.2M | $13.8M |
| FY22 | $186.7M | −$77.6M |
| FY21 | $155.5M | −$113.3M |
| FY20 | $156M | $138.4M |
| FY19 | $128.1M | $69M |
| FY18 | $70.1M | $279.1M |
| FY17 | $26.4M | $158.4M |
| FY16 | $260.5M | $70.3M |
| FY15 | $238.9M | $79.4M |
| FY14 | $183.5M | $47M |
| FY13 | $134.8M | $33.7M |
| FY12 | $103.2M | $19.5M |
| FY11 | $84.2M | $12.8M |
Show the numbers
| Year | Net margin |
|---|---|
| FY25 | 43.6% |
| FY24 | 44.5% |
| FY23 | 5.8% |
| FY22 | −41.6% |
| FY21 | −72.8% |
| FY20 | 88.7% |
| FY19 | 53.9% |
| FY18 | 397.9% |
| FY17 | 599.3% |
| FY16 | 27% |
| FY15 | 33.2% |
| FY14 | 25.6% |
| FY13 | 25% |
| FY12 | 18.9% |
| FY11 | 15.2% |
Show the numbers
| Year | Dividends |
|---|---|
| FY25 | $289.5M |
| FY24 | $280.2M |
| FY23 | $277.4M |
| FY22 | $277.2M |
| FY21 | $262.9M |
| FY20 | $278.3M |
| FY19 | $335.4M |
| FY18 | $325.2M |
| FY17 | $182.1M |
| FY16 | $119.3M |
| FY15 | $109.9M |
| FY14 | $81.5M |
| FY13 | $58.2M |
| FY12 | $48.9M |
| FY11 | $31.6M |
- Sabra Health Care REIT
- Real Estate median
Show the numbers
| Year | Sabra Health Care REIT | Real Estate median |
|---|---|---|
| FY25 | 43.6% | 4.6% |
| FY24 | 44.5% | 4.3% |
| FY23 | 5.8% | 4.4% |
| FY22 | −41.6% | 12.2% |
| FY21 | −72.8% | 10.7% |
| FY20 | 88.7% | 5.1% |
| FY19 | 53.9% | 16% |
| FY18 | 397.9% | 16.1% |
| FY17 | 599.3% | 14.9% |
| FY16 | 27% | 16.7% |
| FY15 | 33.2% | 12.3% |
| FY14 | 25.6% | 11.1% |
| FY13 | 25% | 9.3% |
| FY12 | 18.9% | 10.1% |
| FY11 | 15.2% | 12.4% |